HAIN CELESTIAL GROUP INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HAIN CELESTIAL GROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $619.60M | Aug 29, 2018 |
| FY2018 | Mar 31, 2018 | $632.72M | Aug 29, 2018 |
| FY2018 | Dec 31, 2017 | $616.23M | Aug 29, 2018 |
| FY2018 | Sep 30, 2017 | $589.22M | Aug 29, 2018 |
| FY2018 | Jun 30, 2017 | $602.89M | Aug 29, 2018 |
| FY2018 | Mar 31, 2017 | $588.80M | Aug 29, 2018 |
| FY2018 | Dec 31, 2016 | $587.02M | Aug 29, 2018 |
| FY2018 | Sep 30, 2016 | $564.80M | Aug 29, 2018 |
| FY2018 | Jun 30, 2016 | $2.39B | Aug 29, 2018 |
| FY2017 | Jun 30, 2015 | $2.61B | Sep 13, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.56B | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $1.74B | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $1.80B | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $1.89B | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $1.97B | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $511.75M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $553.30M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $506.78M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $482.08M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | $505.31M | Aug 25, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $725.09M | Sep 13, 2017 |
| FY2017 | Mar 31, 2017 | $706.56M | Sep 13, 2017 |
| FY2017 | Dec 31, 2016 | $740.00M | Sep 13, 2017 |
| FY2017 | Sep 30, 2016 | $681.46M | Sep 13, 2017 |
| FY2017 | Jun 30, 2016 | $737.55M | Sep 13, 2017 |
| FY2017 | Mar 31, 2016 | $736.66M | Sep 13, 2017 |
| FY2017 | Dec 31, 2015 | $743.44M | Sep 13, 2017 |
| FY2017 | Sep 30, 2015 | $667.73M | Sep 13, 2017 |
| FY2016 | Jun 30, 2015 | $680.57M | Jun 22, 2017 |
| FY2016 | Mar 31, 2015 | $652.35M | Jun 22, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $334.06M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $380.83M | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $396.41M | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $427.44M | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $491.62M | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $129.94M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $132.40M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $105.61M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $97.83M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | $95.03M | Aug 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($530.84M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($75.04M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | ($116.54M) | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $77.87M | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $77.36M | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $3.24M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $24.34M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | ($964.0K) | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | ($107.02M) | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | ($13.55M) | Aug 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($461.60M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($18.95M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | ($85.62M) | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $104.68M | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $107.38M | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $25.26M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $19.14M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $9.19M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $2.46M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | ($2.64M) | Aug 25, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.22M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $5.37M | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $6.38M | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $9.42M | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $10.37M | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $11.65M | Aug 25, 2022 |
| FY2021 | Jun 30, 2019 | $11.12M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $9.70M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $10.13M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $11.35M | Aug 29, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $271.83M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $290.12M | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $289.23M | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $300.47M | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $301.78M | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $324.38M | Aug 25, 2022 |
| FY2021 | Jun 30, 2019 | $314.00M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $316.29M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $312.58M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $288.02M | Aug 29, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $22.12M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $116.36M | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $66.82M | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $80.24M | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $196.76M | Aug 24, 2023 |
| FY2018 | Jun 30, 2018 | $121.31M | Aug 29, 2018 |
| FY2018 | Jun 30, 2017 | $232.70M | Aug 29, 2018 |
| FY2018 | Jun 30, 2016 | $184.97M | Aug 29, 2018 |
| FY2017 | Jun 30, 2015 | $185.48M | Sep 13, 2017 |
| FY2016 | Jun 30, 2014 | $184.77M | Jun 22, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.60B | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $2.12B | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $2.26B | Aug 27, 2024 |
| FY2023 | Jun 30, 2022 | $2.46B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $2.21B | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $2.19B | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | $2.58B | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $2.95B | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $2.93B | Aug 29, 2018 |
| FY2017 | Jun 30, 2016 | $3.01B | Sep 13, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.13B | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $1.17B | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $1.24B | Aug 27, 2024 |
| FY2023 | Jun 30, 2022 | $1.38B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $683.03M | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $744.90M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | $1.06B | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $1.21B | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $1.22B | Aug 29, 2018 |
| FY2017 | Jun 30, 2016 | $1.34B | Sep 13, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $475.01M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $942.91M | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $1.02B | Sep 15, 2025 |
| FY2025 | Jun 30, 2022 | $1.08B | Sep 15, 2025 |
| FY2024 | Jun 30, 2021 | $1.52B | Aug 27, 2024 |
| FY2023 | Jun 30, 2020 | $1.44B | Aug 24, 2023 |
| FY2022 | Jun 30, 2019 | $1.52B | Aug 25, 2022 |
| FY2021 | Jun 30, 2018 | $1.74B | Aug 26, 2021 |
| FY2020 | Jun 30, 2017 | $1.71B | Aug 25, 2020 |
| FY2019 | Jun 30, 2016 | $1.66B | Aug 29, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $500.96M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $929.30M | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $938.64M | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $933.80M | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | $871.07M | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $861.96M | Aug 25, 2022 |
| FY2021 | Jun 30, 2019 | $875.88M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $885.66M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $1.02B | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $1.02B | Aug 29, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $46.68M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $577.52M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $652.56M | Aug 27, 2024 |
| FY2023 | Jun 30, 2022 | $769.10M | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $691.23M | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $614.17M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | $695.02M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $878.52M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $868.82M | Aug 29, 2018 |
| FY2017 | Jun 30, 2016 | $801.39M | Sep 13, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $54.36M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $54.31M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $53.36M | Aug 27, 2024 |
| FY2023 | Jun 30, 2022 | $65.51M | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $75.87M | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $37.77M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | $31.02M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $106.56M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $137.06M | Aug 29, 2018 |
| FY2018 | Jun 30, 2016 | $114.99M | Aug 29, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $706.66M | Sep 15, 2025 |
| FY2024 | Jun 30, 2024 | $745.77M | Aug 27, 2024 |
| FY2023 | Jun 30, 2023 | $828.75M | Aug 24, 2023 |
| FY2023 | Jun 30, 2022 | $888.64M | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $231.02M | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $282.77M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | $630.77M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $714.11M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $749.76M | Aug 29, 2018 |
| FY2017 | Jun 30, 2016 | $862.68M | Sep 13, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (5) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | (1) | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | (1) | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (5) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | (1) | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Aug 27, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | (1) | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 90.28M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 89.85M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | 89.48M | Aug 27, 2024 |
| FY2023 | Jun 30, 2022 | 89.30M | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | 99.07M | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | 101.89M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | 104.22M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | 103.95M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | 103.70M | Aug 29, 2018 |
| FY2017 | Jun 30, 2016 | 103.46M | Sep 13, 2017 |